Showing results (141-150 of 261) with videos related to
Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|October 11, 2020
Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuji Matsumoto, et al.Journal of Radiation Research|October 30, 2010
Acute adverse effects of radiation therapy on HIV-positive patients in Japan: study of 31 cases at Tokyo Metropolitan Komagome HospitalTakuya Kaminuma, Katsuyuki Karasawa, Nahoko Hanyu, et al.Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modificationYukiko Igawa, Tatsuya Yoshida, Reiko Makihara, et al.Cancer Immunology, Immunotherapy : CII|June 28, 2021
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumabHitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, et al.Journal of Cancer Research and Clinical Oncology|April 26, 2024
Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysisKentaro Tamura, Yusuke Okuma, Shogo Nomura, et al.Japanese Journal of Clinical Oncology|February 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case seriesTomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida, et al.The Oncologist|September 28, 2014
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancerYusuke Takagi, Yukio Hosomi, Kuniko Sunami, et al.Journal of Cancer Research and Clinical Oncology|July 25, 2020
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expressionKen Masuda, Hidehito Horinouchi, Midori Tanaka, et al.Respiratory Medicine Case Reports|May 7, 2020
Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumoniaTakehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, et al.FEBS Open Bio|August 28, 2014
The zinc-binding region (ZBR) fragment of Emi2 can inhibit APC/C by targeting its association with the coactivator Cdc20 and UBE2C-mediated ubiquitylationShisako Shoji, Yutaka Muto, Mariko Ikeda, et al.Pageof 27